share_log

Doximity, Inc. (NASDAQ:DOCS) Receives Consensus Recommendation of "Moderate Buy" From Brokerages

Defense World ·  Sep 24, 2022 02:21

Shares of Doximity, Inc. (NASDAQ:DOCS – Get Rating) have earned an average rating of "Hold" from the seventeen ratings firms that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and eight have given a buy rating to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $47.53.

DOCS has been the topic of several research analyst reports. KeyCorp initiated coverage on shares of Doximity in a report on Thursday, September 15th. They set a "sector weight" rating on the stock. Berenberg Bank restated an "initiates" rating on shares of Doximity in a report on Friday, July 29th. Piper Sandler lowered their price target on shares of Doximity from $44.00 to $39.00 in a report on Friday, August 5th. Truist Financial began coverage on shares of Doximity in a report on Wednesday, September 7th. They issued a "hold" rating and a $35.00 price objective for the company. Finally, Canaccord Genuity Group decreased their price objective on shares of Doximity from $47.00 to $42.00 and set a "buy" rating for the company in a report on Friday, August 5th.

Get Doximity alerts:

Doximity Price Performance

Shares of NASDAQ:DOCS opened at $30.52 on Friday. Doximity has a 12 month low of $27.06 and a 12 month high of $91.25. The stock has a market cap of $5.90 billion, a price-to-earnings ratio of 43.60, a PEG ratio of 15.55 and a beta of 0.95. The stock's 50 day moving average price is $36.36 and its 200 day moving average price is $39.64.

Doximity (NASDAQ:DOCS – Get Rating) last announced its earnings results on Thursday, August 4th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.07 by $0.03. Doximity had a return on equity of 17.99% and a net margin of 41.72%. The firm had revenue of $90.64 million for the quarter, compared to analysts' expectations of $89.34 million. On average, sell-side analysts expect that Doximity will post 0.54 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of DOCS. FMR LLC raised its position in shares of Doximity by 42.3% during the second quarter. FMR LLC now owns 7,737,391 shares of the company's stock valued at $269,416,000 after buying an additional 2,298,400 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Doximity by 81.2% during the first quarter. Vanguard Group Inc. now owns 7,501,908 shares of the company's stock valued at $390,774,000 after buying an additional 3,362,575 shares during the last quarter. Clearbridge Investments LLC raised its position in shares of Doximity by 67.1% during the second quarter. Clearbridge Investments LLC now owns 4,482,772 shares of the company's stock valued at $156,090,000 after buying an additional 1,799,896 shares during the last quarter. Allianz Asset Management GmbH raised its position in shares of Doximity by 153.8% during the first quarter. Allianz Asset Management GmbH now owns 4,170,440 shares of the company's stock valued at $217,238,000 after buying an additional 2,527,010 shares during the last quarter. Finally, Loomis Sayles & Co. L P raised its position in shares of Doximity by 22.9% during the second quarter. Loomis Sayles & Co. L P now owns 2,727,492 shares of the company's stock valued at $94,971,000 after buying an additional 508,556 shares during the last quarter. Institutional investors and hedge funds own 46.99% of the company's stock.

About Doximity

(Get Rating)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

See Also

  • Get a free copy of the StockNews.com research report on Doximity (DOCS)
  • MarketBeat: Week in Review 9/19 – 9/23
  • Why Does Tesla Stock Remain Resilient?
  • Will Crowdstrike Get A Boost From Increased EPS Guidance?
  • 2 Semiconductor Stocks To Watch For Reversals
  • Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment